TAAR1 and nervous system disorder: With an established function of TAAR1 in the CNS and the availability of selective and safe TAAR1 agonists, pharmacologically targeting TAAR1 within the CNS has resulted in successful clinical trials for treatment of neurological disorders, such as schizophrenia [7,8], which also is accompanied by an inflammatory component [9].